Sector consensus Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 16/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 49.37 USD | -1.26% |
|
-9.61% | +12.08% |
| 09-15 | Scholar Rock Shares Fall After Barclays Downgrade | MT |
| 09-15 | Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 69.94 | +39.88% | 16 | ||||||
| 187.07 | +19.4% | 18 | ||||||
| 1,179.34 | +18.95% | 15 | ||||||
| 199.55 | +66.4% | 22 | ||||||
| 49.74 | +18.1% | 24 | ||||||
| 102.58 | +22.48% | 20 | ||||||
| 2,453.79 | +14.13% | 15 | ||||||
| 1,397.26 | +15.96% | 8 | ||||||
| 53.69 | -5.65% | 16 | ||||||
| 619.67 | +34.01% | 19 | ||||||
| 21.57 | +67.21% | 13 | ||||||
| 678.06 | +29.58% | 16 | ||||||
| 133.94 | +64.26% | 21 | ||||||
| 110 | +55.65% | 12 | ||||||
| 109.9 | +58.56% | 20 | ||||||
| 109 | +84.09% | 9 | ||||||
| 12.75 | +56.63% | 4 | ||||||
| 100.16 | +55.08% | 16 | ||||||
| 120.08 | +32.03% | 13 | ||||||
| 228.89 | +35.09% | 9 | ||||||
| Average | 396.85 | +39.09% | 15 | ||||||
| Weighted average by Cap. | 515.7 | +31.26% | 17 |
- Stock Market
- Stocks
- SRRK Stock
- Sector Scholar Rock Holding Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
